TY - JOUR
T1 - Influence of residue 22 on the folding, aggregation profile, and toxicity of the Alzheimer's amyloid β peptide
AU - Perálvarez-Marín, Alex
AU - Mateos, Laura
AU - Zhang, Ce
AU - Singh, Shalini
AU - Cedazo-Mínguez, Ángel
AU - Visa, Neus
AU - Morozova-Roche, Ludmilla
AU - Gräslund, Astrid
AU - Barth, Andreas
N1 - Funding Information:
This work was supported by grants from the Swedish Research Council (to A.G.) and Knut och Alice Wallenbergs Stiftelse (to A.B.), and a Catalan Government Postdoctoral Fellowship “Beatriu de Pinos” (2005 BP-A 10085 to A.P.-M.). Further support was obtained from the European Commission (contract LSHG-CT-2004-512052), the Carl Trygger Foundation, the Marianne and Marcus Wallenberg Foundation, the Swedish Foundation for Strategic Research (Bio-X), and the Swedish Brain Foundation.
PY - 2009/7/18
Y1 - 2009/7/18
N2 - Several biophysical techniques have been used to determine differences in the aggregation profile (i.e., the secondary structure, aggregation propensity, dynamics, and morphology of amyloid structures) and the effects on cell viability of three variants of the amyloid β peptide involved in Alzheimer's disease. We focused our study on the Glu22 residue, comparing the effects of freshly prepared samples and samples aged for at least 20 days. In the aged samples, a high propensity for aggregation and β-sheet secondary structure appears when residue 22 is capable of establishing polar (Glu22 in wild-type) or hydrophobic (Val22 in E22V) interactions. The Arctic variant (E22G) presents a mixture of mostly disordered and a-helix structures (with low β-sheet contribution). Analysis of transmission electron micrographs and atomic force microscopy images of the peptide variants after aging showed significant quantitative and qualitative differences in the morphology of the formed aggregates. The effect on human neuroblastoma cells of these Aβ12-28 variants does not correlate with the amount of β-sheet of the aggregates. In samples allowed to age, the native sequence was found to have an insignificant effect on cell viability, whereas the Arctic variant (E22G), the E22V variant, and the slightly-aggregating control (F19G-F20G) had more prominent effects.
AB - Several biophysical techniques have been used to determine differences in the aggregation profile (i.e., the secondary structure, aggregation propensity, dynamics, and morphology of amyloid structures) and the effects on cell viability of three variants of the amyloid β peptide involved in Alzheimer's disease. We focused our study on the Glu22 residue, comparing the effects of freshly prepared samples and samples aged for at least 20 days. In the aged samples, a high propensity for aggregation and β-sheet secondary structure appears when residue 22 is capable of establishing polar (Glu22 in wild-type) or hydrophobic (Val22 in E22V) interactions. The Arctic variant (E22G) presents a mixture of mostly disordered and a-helix structures (with low β-sheet contribution). Analysis of transmission electron micrographs and atomic force microscopy images of the peptide variants after aging showed significant quantitative and qualitative differences in the morphology of the formed aggregates. The effect on human neuroblastoma cells of these Aβ12-28 variants does not correlate with the amount of β-sheet of the aggregates. In samples allowed to age, the native sequence was found to have an insignificant effect on cell viability, whereas the Arctic variant (E22G), the E22V variant, and the slightly-aggregating control (F19G-F20G) had more prominent effects.
UR - http://www.scopus.com/inward/record.url?scp=68949149540&partnerID=8YFLogxK
U2 - 10.1016/j.bpj.2009.04.017
DO - 10.1016/j.bpj.2009.04.017
M3 - Article
C2 - 19580765
AN - SCOPUS:68949149540
SN - 0006-3495
VL - 97
SP - 277
EP - 285
JO - Biophysical Journal
JF - Biophysical Journal
IS - 1
ER -